Bacterial Polyphosphate Kinases Revisited: Role in Pathogenesis and Therapeutic Potential

Abstract

Bacterial infections have always been an unrestrained challenge to the medical community due to the rise of multi-drug tolerant and resistant strains. Pioneering work on Escherichia coli polyphosphate kinase (PPK) by Arthur Kornberg has generated great interest in this polyphosphate (PolyP) synthesizing enzyme. PPK has wide distribution among pathogens and is involved in promoting pathogenesis, stress management and susceptibility to antibiotics. Further, the absence of a PPK orthologue in humans makes it a potential drug target. This review covers the functional and structural aspects of polyphosphate kinases in bacterial pathogens. A description of molecules being designed against PPKs has been provided, challenges associated with PPK inhibitor design are highlighted and the strategies to enable development of efficient drug against this enzyme have also been discussed.

Publication
Current Drug Targets. 2019;20(3) 292-301
Click the Cite button above to demo the feature to enable visitors to import publication metadata into their reference management software.
Lalit Kumar Gautam
Lalit Kumar Gautam
Post Doctoral Scholar

My research interests include application of data science in medicine and healthcare.

Related